346 related articles for article (PubMed ID: 29462566)
1. Nonalcoholic fatty liver disease and gastric bypass surgery regulate serum and hepatic levels of pyruvate kinase isoenzyme M2.
Meoli L; Gupta NK; Saeidi N; Panciotti CA; Biddinger SB; Corey KE; Stylopoulos N
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E613-E621. PubMed ID: 29462566
[TBL] [Abstract][Full Text] [Related]
2. HSPA12A Is a Novel Player in Nonalcoholic Steatohepatitis via Promoting Nuclear PKM2-Mediated M1 Macrophage Polarization.
Kong Q; Li N; Cheng H; Zhang X; Cao X; Qi T; Dai L; Zhang Z; Chen X; Li C; Li Y; Xue B; Fang L; Liu L; Ding Z
Diabetes; 2019 Feb; 68(2):361-376. PubMed ID: 30455376
[TBL] [Abstract][Full Text] [Related]
3. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy and lactation after Roux-en-Y gastric bypass worsen nonalcoholic fatty liver disease in obese rats and lead to differential programming of hepatic
Bertasso IM; Pietrobon CB; Ribeiro RA; Soares GM; Oliveira JC; Alegre-Maller ACP; Boschero AC; Araújo ACF; Guimarães ATB; Bonfleur ML; Balbo SL
J Dev Orig Health Dis; 2022 Apr; 13(2):263-273. PubMed ID: 33998431
[TBL] [Abstract][Full Text] [Related]
5. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
[TBL] [Abstract][Full Text] [Related]
6. Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.
de Brito E Silva MB; Tustumi F; de Miranda Neto AA; Dantas ACB; Santo MA; Cecconello I
Obes Surg; 2021 Jun; 31(6):2762-2772. PubMed ID: 33846949
[TBL] [Abstract][Full Text] [Related]
7. Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery.
Chen F; Zhou Y; Wu Z; Li Y; Zhou W; Wang Y
Front Endocrinol (Lausanne); 2020; 11():611213. PubMed ID: 33603714
[TBL] [Abstract][Full Text] [Related]
8. Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.
Lalloyer F; Mogilenko DA; Verrijken A; Haas JT; Lamazière A; Kouach M; Descat A; Caron S; Vallez E; Derudas B; Gheeraert C; Baugé E; Despres G; Dirinck E; Tailleux A; Dombrowicz D; Van Gaal L; Eeckhoute J; Lefebvre P; Goossens JF; Francque S; Staels B
J Hepatol; 2023 Oct; 79(4):898-909. PubMed ID: 37230231
[TBL] [Abstract][Full Text] [Related]
9. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
10. In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control.
Schwenger KJP; Fischer SE; Jackson T; Okrainec A; Allard JP
Surg Obes Relat Dis; 2018 Sep; 14(9):1233-1239. PubMed ID: 30049593
[TBL] [Abstract][Full Text] [Related]
11. Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.
Perdomo CM; Gómez-Ambrosi J; Becerril S; Valentí V; Moncada R; Fernández-Sáez EM; Méndez-Giménez L; Ezquerro S; Catalán V; Silva C; Escalada J; Frühbeck G; Rodríguez A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884755
[TBL] [Abstract][Full Text] [Related]
12. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
[TBL] [Abstract][Full Text] [Related]
13. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
[TBL] [Abstract][Full Text] [Related]
14. Treatment of NASH with Gastric Bypass.
Jirapinyo P; Thompson CC
Curr Gastroenterol Rep; 2018 Sep; 20(10):49. PubMed ID: 30244334
[TBL] [Abstract][Full Text] [Related]
15. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
[TBL] [Abstract][Full Text] [Related]
16. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.
Caiazzo R; Lassailly G; Leteurtre E; Baud G; Verkindt H; Raverdy V; Buob D; Pigeyre M; Mathurin P; Pattou F
Ann Surg; 2014 Nov; 260(5):893-8; discussion 898-9. PubMed ID: 25379859
[TBL] [Abstract][Full Text] [Related]
17. Weight-independent effects of Roux-en-Y gastric bypass surgery on remission of nonalcoholic fatty liver disease in mice.
Axelrod CL; Langohr I; Dantas WS; Heintz EC; Vandanmagsar B; Yang S; Zunica ERM; Townsend RL; Albaugh VL; Berthoud HR; Kirwan JP
Obesity (Silver Spring); 2023 Dec; 31(12):2960-2971. PubMed ID: 37731222
[TBL] [Abstract][Full Text] [Related]
18. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis.
Verbeek J; Lannoo M; Pirinen E; Ryu D; Spincemaille P; Vander Elst I; Windmolders P; Thevissen K; Cammue BP; van Pelt J; Fransis S; Van Eyken P; Ceuterick-De Groote C; Van Veldhoven PP; Bedossa P; Nevens F; Auwerx J; Cassiman D
Gut; 2015 Apr; 64(4):673-83. PubMed ID: 24917551
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate kinase M2 regulates apoptosis of intestinal epithelial cells in Crohn's disease.
Tang Q; Ji Q; Xia W; Li L; Bai J; Ni R; Qin Y
Dig Dis Sci; 2015 Feb; 60(2):393-404. PubMed ID: 24817408
[TBL] [Abstract][Full Text] [Related]
20. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
